To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CCDC80TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
669 representative clones for gene CCDC80 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DC392664 stomach CCDC80.a 1 to 556 2 to 557   tiling clone,   557/557
(100 %)
1 diff
(99.9 %id)
DC373078 tongue CCDC80.a 136 to 616 9 to 490       482/482
(100 %)
2 diff
(99.6 %id)
DA552868   CCDC80.a 158 to 711 2 to 556   tiling clone, capped   555/555
(100 %)
3 diff
(99.5 %id)
NM_199512.1   CCDC80.a 170 to 4093 1 to 3924 exact RefSeq, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 3924/3924
(100 %)
0 diff
(100 %id)
DA661772   CCDC80.a 182 to 726 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA668945 esophagus CCDC80.a 183 to 714 2 to 532   capped   531/531
(100 %)
2 diff
(99.7 %id)
CF125504 Chondrosarcoma Lung Metastasis cell lines, lung CCDC80.a 215 to 766 1 to 552       552/552
(100 %)
0 diff
(100 %id)
CF125577 Chondrosarcoma Lung Metastasis cell lines, lung CCDC80.a 215 to 856 1 to 641   tiling clone,   641/643
(99 %)
2 diff
(99.7 %id)
TI_154187258   CCDC80.a 215 to 984 125 to 890       766/767
(99 %)
11 diff
(98.6 %id)
TI_154187738   CCDC80.a 215 to 1025 138 to 941       804/950
(84 %)
9 diff
(99.1 %id)
DA449650 tongue, tumor tissue CCDC80.a 224 to 802 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA546743   CCDC80.a 232 to 787 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
AF506819   CCDC80.a 242 to 3557 1 to 3315 P397X tiling clone,   3315/3320
(99 %)
6 diff
(99.9 %id)
BG122734 adenocarcinoma, cell line, Liver CCDC80.a 242 to 975 1 to 739       739/749
(98 %)
16 diff
(97.9 %id)
DA971110 synovial membrane tissue from rheumatioidarthritis CCDC80.a 243 to 749 2 to 508   capped   507/507
(100 %)
0 diff
(100 %id)
CN373001 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells CCDC80.a 253 to 707 19 to 473       455/473
(96 %)
7 diff
(98.6 %id)
DA554624   CCDC80.a 261 to 819 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA562223 heart CCDC80.a 261 to 820 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA996968   CCDC80.a 261 to 759 2 to 500   capped   499/499
(100 %)
0 diff
(100 %id)
CN372981 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells CCDC80.a 271 to 957 1 to 688       688/688
(100 %)
5 diff
(99.3 %id)
DA596349   CCDC80.a 271 to 833 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
TI_154195258   CCDC80.a 275 to 1180 51 to 940       890/1025
(86 %)
19 diff
(98.2 %id)
ES310709 scalp interfollicular dermis, skin CCDC80.a 291 to 868 26 to 615       590/619
(95 %)
23 diff
(96.3 %id)
DA988939 synovial membrane tissue from rheumatioidarthritis CCDC80.a 353 to 830 2 to 480   capped   479/479
(100 %)
1 diff
(99.8 %id)
TI_154194093   CCDC80.a 2448 to 3389 51 to 1051       941/1055
(89 %)
41 diff
(96.2 %id)
TI_154091414   CCDC80.a 2698 to 3391 778 to 85   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 694/950
(73 %)
34 diff
(96.5 %id)
BU686057 lung, Primary Lung Epithelial Cells CCDC80.a 2704 to 3391 703 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 685/688
(99 %)
3 diff
(99.6 %id)
BQ574307 Chondrosarcoma Grade II, Left Pelvis CCDC80.a 2704 to 3391 704 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 686/689
(99 %)
2 diff
(99.8 %id)
BQ004916 Chondrosarcoma, Left Pelvis CCDC80.a 2712 to 3391 697 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 679/684
(99 %)
3 diff
(99.6 %id)
BM976726 lung, Primary Lung Cystic Fibrosis EpithelialCells CCDC80.a 2714 to 3391 696 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 678/678
(100 %)
0 diff
(100 %id)
CA418332 Bone, Human Chondrosarcoma Cell Line CCDC80.a 2714 to 3391 696 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 678/678
(100 %)
0 diff
(100 %id)
BM990620 lung, Lung Focal Fibrosis CCDC80.a 2715 to 3391 695 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 677/677
(100 %)
0 diff
(100 %id)
AW173315 pooled CCDC80.a 2719 to 3392 675 to 3       673/675
(99 %)
7 diff
(99.0 %id)
CA420480 Bone, Enchondroma cell line CCDC80.a 2722 to 3387 682 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 664/664
(100 %)
5 diff
(99.3 %id)
BQ018570 lung, Metastatic Chondrosarcoma CCDC80.a 2724 to 3391 685 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 667/667
(100 %)
1 diff
(99.9 %id)
CA438284 lung, Metastatic Chondrosarcoma CCDC80.a 2727 to 3391 683 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 665/665
(100 %)
0 diff
(100 %id)
BM997574 lung, Metastatic Chondrosarcoma CCDC80.a 2730 to 3391 680 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 662/662
(100 %)
0 diff
(100 %id)
CA412054 Chondrosarcoma Grade II, Left Pelvis CCDC80.a 2733 to 3391 677 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 659/659
(100 %)
1 diff
(99.9 %id)
AW303375 pooled CCDC80.a 2734 to 3392 659 to 1       659/659
(100 %)
3 diff
(99.6 %id)
CA439086 lung, Lung Focal Fibrosis CCDC80.a 2743 to 3391 667 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 649/649
(100 %)
1 diff
(99.9 %id)
AA417652 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus CCDC80.a 2744 to 3154 1 to 411   fully sequenced, Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 411/411
(100 %)
0 diff
(100 %id)
BQ016610 lung, Metastatic Chondrosarcoma CCDC80.a 2744 to 3392 666 to 18       649/666
(97 %)
1 diff
(99.9 %id)
CA439079 lung, Lung Focal Fibrosis CCDC80.a 2745 to 3391 665 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 647/647
(100 %)
0 diff
(100 %id)
BQ775359 Bone, Human Chondrosarcoma Cell Line CCDC80.a 2745 to 3391 664 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 646/646
(100 %)
1 diff
(99.9 %id)
BQ182326 Knee, Osteoarthritic Cartilage CCDC80.a 2751 to 3391 659 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 641/643
(99 %)
3 diff
(99.6 %id)
BG939153 Bone, Hip CCDC80.a 2751 to 3371 629 to 9       621/629
(98 %)
0 diff
(100 %id)
CA421799 Bone, Enchondroma cell line CCDC80.a 2766 to 3391 644 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 626/626
(100 %)
0 diff
(100 %id)
BU633427 cell lines, Chondrosarcoma CCDC80.a 2770 to 3391 640 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 622/622
(100 %)
0 diff
(100 %id)
CA420577 Bone, Enchondroma cell line CCDC80.a 2790 to 3391 620 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 602/602
(100 %)
1 diff
(99.9 %id)
AI090486 heart CCDC80.a 2897 to 3392 496 to 1       496/496
(100 %)
0 diff
(100 %id)
AA258414 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus CCDC80.a 2902 to 3271 1 to 370   fully sequenced,   370/370
(100 %)
0 diff
(100 %id)
BG252401 adenocarcinoma, cell line, Liver CCDC80.a 2914 to 3551 1 to 644   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 644/644
(100 %)
8 diff
(98.8 %id)
AW631492 pooled CCDC80.a 2920 to 3392 478 to 6       473/478
(98 %)
0 diff
(100 %id)
BE378218 endometrium, adenocarcinoma cell line, uterus CCDC80.a 2935 to 3389 1 to 455       455/455
(100 %)
0 diff
(100 %id)
AA599207 bone marrow stroma CCDC80.a 2941 to 3386 446 to 1       446/446
(100 %)
0 diff
(100 %id)
BM995434 Chondrosarcoma, Left Pubic Bone CCDC80.a 2946 to 3566 639 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 621/621
(100 %)
0 diff
(100 %id)
BX094547 heart CCDC80.a 2959 to 3699 1 to 741   tiling clone,   741/748
(99 %)
1 diff
(99.9 %id)
AA419525 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus CCDC80.a 2962 to 3378 1 to 416   fully sequenced,   416/416
(100 %)
2 diff
(99.6 %id)
AI272646 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus CCDC80.a 2965 to 3392 428 to 1       428/428
(100 %)
0 diff
(100 %id)
AW957682   CCDC80.a 2988 to 3391 1 to 404   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 404/404
(100 %)
0 diff
(100 %id)
BI493797 cochlea, ear CCDC80.a 2988 to 3391 1 to 404   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 404/404
(100 %)
5 diff
(98.8 %id)
AI754332 bone marrow stroma CCDC80.a 2995 to 3391 417 to 21   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 397/397
(100 %)
0 diff
(100 %id)
BM694671 eye, RPE and Choroid CCDC80.a 2996 to 3361 1 to 366   fully sequenced, Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 366/366
(100 %)
6 diff
(98.4 %id)
BG034853 adenocarcinoma, cell line, Liver CCDC80.a 3003 to 3764 1 to 750   tiling clone,   750/935
(80 %)
15 diff
(98.4 %id)
BI493796 cochlea, ear CCDC80.a 3033 to 3391 383 to 25   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 359/359
(100 %)
0 diff
(100 %id)
AI754989 bone marrow stroma CCDC80.a 3044 to 3391 366 to 19   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 348/348
(100 %)
0 diff
(100 %id)
AA478719 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus CCDC80.a 3066 to 3391 326 to 1       326/326
(100 %)
0 diff
(100 %id)
BF447303 Prostate CCDC80.a 3077 to 3555 489 to 11   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 479/479
(100 %)
0 diff
(100 %id)
CF130139 Chondrosarcoma Lung Metastasis cell lines, lung CCDC80.a 3082 to 3566 1 to 485   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 485/485
(100 %)
0 diff
(100 %id)
TI_154192070   CCDC80.a 3082 to 3566 51 to 535   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 485/485
(100 %)
0 diff
(100 %id)
BF197986 skin, normal, 4 pooled samples CCDC80.a 3087 to 3391 305 to 1       305/305
(100 %)
0 diff
(100 %id)
AI221431 pooled CCDC80.a 3098 to 3391 294 to 1       294/294
(100 %)
0 diff
(100 %id)
AA456579 ovarian tumor, ovary CCDC80.a 3123 to 3391 269 to 1       269/269
(100 %)
0 diff
(100 %id)
AA419609 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus CCDC80.a 3124 to 3391 284 to 16   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 269/269
(100 %)
1 diff
(99.7 %id)
BU731195 eye, RPE and Choroid CCDC80.a 3162 to 3390 247 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 229/229
(100 %)
0 diff
(100 %id)
AA258397 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus CCDC80.a 3241 to 3392 152 to 1   fully sequenced,   152/152
(100 %)
0 diff
(100 %id)
AA410897 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus CCDC80.a 3243 to 3395 153 to 1   fully sequenced,   153/153
(100 %)
3 diff
(98.1 %id)
DA543787   CCDC80.b 1 to 555 2 to 558   tiling clone, capped   557/557
(100 %)
3 diff
(99.5 %id)
DB224851 trachea CCDC80.b 30 to 587 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
DA257136 caudate nucleus CCDC80.b 82 to 598 2 to 518   tiling clone, capped   517/517
(100 %)
1 diff
(99.9 %id)
BX473178   CCDC80.b 117 to 698 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
DW424504 Liver CCDC80.b 118 to 388 18 to 288       271/288
(94 %)
6 diff
(98.0 %id)
DW444877 Liver CCDC80.b 118 to 324 18 to 224       207/224
(92 %)
11 diff
(95.1 %id)
DW447303 Liver CCDC80.b 118 to 313 18 to 213       196/213
(92 %)
6 diff
(97.2 %id)
DA021077   CCDC80.b 119 to 692 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
DA030123   CCDC80.b 119 to 681 2 to 564   capped   563/563
(100 %)
2 diff
(99.7 %id)
DA030597   CCDC80.b 119 to 699 2 to 583   capped   582/582
(100 %)
3 diff
(99.5 %id)
DA472483   CCDC80.b 119 to 616 2 to 499   capped   498/498
(100 %)
1 diff
(99.8 %id)
DA549933   CCDC80.b 119 to 715 2 to 597   capped   596/596
(100 %)
2 diff
(99.7 %id)
DB211331 trachea CCDC80.b 119 to 641 2 to 525   capped   524/524
(100 %)
4 diff
(99.3 %id)
DA764187 tongue CCDC80.b 124 to 709 2 to 587   capped   586/586
(100 %)
1 diff
(99.9 %id)
DA423502   CCDC80.b 131 to 691 2 to 562   capped   561/561
(100 %)
2 diff
(99.7 %id)
AB266387   CCDC80.b 149 to 4107 63 to 4021 P460X     3959/3970
(99 %)
6 diff
(99.9 %id)
CN372973 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells CCDC80.b 150 to 770 1 to 621       621/621
(100 %)
1 diff
(99.9 %id)
DA930601 small intestine CCDC80.b 251 to 844 2 to 595   capped   594/594
(100 %)
1 diff
(99.9 %id)
DA580695   CCDC80.b 268 to 829 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA556951   CCDC80.b 269 to 860 2 to 595   capped   594/594
(100 %)
2 diff
(99.7 %id)
DA023178   CCDC80.b 276 to 842 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DA030509   CCDC80.b 276 to 846 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
DA374403 thalamus CCDC80.b 276 to 815 2 to 541   capped   540/540
(100 %)
1 diff
(99.9 %id)
DA552528   CCDC80.b 276 to 853 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
DA558133   CCDC80.b 276 to 848 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DA574769   CCDC80.b 276 to 830 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA575656   CCDC80.b 276 to 815 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
DA576738   CCDC80.b 276 to 850 2 to 576   capped   575/575
(100 %)
3 diff
(99.5 %id)
DA579201   CCDC80.b 276 to 819 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DA689631   CCDC80.b 276 to 812 2 to 538   capped   537/537
(100 %)
3 diff
(99.5 %id)
DA699315   CCDC80.b 276 to 787 2 to 513   capped   512/512
(100 %)
2 diff
(99.7 %id)
DA761136 tongue CCDC80.b 276 to 806 2 to 532   capped   531/531
(100 %)
3 diff
(99.5 %id)
DA879522 Prostate CCDC80.b 276 to 848 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DA938337 Spleen CCDC80.b 276 to 870 2 to 596   capped   595/595
(100 %)
1 diff
(99.9 %id)
DB250555 uterus CCDC80.b 276 to 899 2 to 625   capped   624/624
(100 %)
1 diff
(99.9 %id)
DB286883 uterus CCDC80.b 276 to 839 2 to 565   capped   564/564
(100 %)
2 diff
(99.7 %id)
DB287568 uterus CCDC80.b 276 to 855 2 to 581   capped   580/580
(100 %)
3 diff
(99.5 %id)
AL598163   CCDC80.b 277 to 756 1 to 480       480/480
(100 %)
3 diff
(99.4 %id)
DA578445   CCDC80.b 278 to 828 2 to 552   capped   551/551
(100 %)
2 diff
(99.7 %id)
DA543255   CCDC80.b 279 to 841 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DA554453   CCDC80.b 279 to 825 2 to 549   capped   548/548
(100 %)
3 diff
(99.5 %id)
DA576793   CCDC80.b 279 to 851 2 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
AU311826 neuroblastoma CCDC80.b 279 to 856 1 to 577       577/577
(100 %)
2 diff
(99.7 %id)
DA028994   CCDC80.b 280 to 854 2 to 577   capped   576/576
(100 %)
2 diff
(99.7 %id)
DA029329   CCDC80.b 280 to 843 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA473195   CCDC80.b 280 to 838 2 to 560   capped   559/559
(100 %)
2 diff
(99.7 %id)
DA580482   CCDC80.b 280 to 828 2 to 550   capped   549/549
(100 %)
2 diff
(99.7 %id)
DA663275   CCDC80.b 280 to 841 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DB070163 testis CCDC80.b 280 to 810 2 to 533   capped   532/532
(100 %)
1 diff
(99.9 %id)
DA028778   CCDC80.b 281 to 835 2 to 557   capped   556/556
(100 %)
2 diff
(99.7 %id)
DA424068   CCDC80.b 281 to 855 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
DA020988   CCDC80.b 283 to 860 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
DA033519   CCDC80.b 283 to 850 2 to 569   capped   568/569
(99 %)
1 diff
(99.9 %id)
DA576003   CCDC80.b 283 to 853 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA578030   CCDC80.b 283 to 851 2 to 570   capped   569/569
(100 %)
2 diff
(99.7 %id)
BX485907   CCDC80.b 284 to 1034 1 to 751       751/751
(100 %)
0 diff
(100 %id)
CN372999 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 CCDC80.b 285 to 970 1 to 688       688/688
(100 %)
7 diff
(99.0 %id)
DA836383 placenta CCDC80.b 285 to 836 2 to 553   capped   552/553
(99 %)
1 diff
(99.9 %id)
DA967693 stomach CCDC80.b 285 to 835 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA996613   CCDC80.b 285 to 770 2 to 487   capped   486/486
(100 %)
1 diff
(99.8 %id)
DB260415 uterus CCDC80.b 285 to 851 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
AY526612   CCDC80.b 288 to 4102 1 to 3816 exact AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 3816/3816
(100 %)
2 diff
(100.0 %id)
DA559054   CCDC80.b 288 to 837 2 to 551   capped   550/550
(100 %)
3 diff
(99.5 %id)
NM_199511.1   CCDC80.b 288 to 4808 1 to 4521 exact RefSeq, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 4521/4521
(100 %)
0 diff
(100 %id)
BM787873 stomach CCDC80.b 288 to 811 1 to 524       524/524
(100 %)
0 diff
(100 %id)
BC110842 Peripheral Nervous System, sciatic nerve CCDC80.b 290 to 4106 1 to 3817 exact AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 3817/3817
(100 %)
0 diff
(100 %id)
BQ926784 sciatic nerve CCDC80.b 291 to 1089 1 to 799       799/913
(87 %)
1 diff
(99.9 %id)
DA574023   CCDC80.b 292 to 863 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
BG035195 adenocarcinoma, cell line, Liver CCDC80.b 295 to 1089 1 to 790       790/886
(89 %)
24 diff
(97.3 %id)
CN482531 eye CCDC80.b 296 to 813 1 to 518       518/518
(100 %)
0 diff
(100 %id)
BX951483   CCDC80.b 297 to 950 1 to 652       652/652
(100 %)
2 diff
(99.7 %id)
DB049516 testis CCDC80.b 298 to 864 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
DA549809   CCDC80.b 299 to 782 2 to 485   capped   484/484
(100 %)
1 diff
(99.8 %id)
DA578136   CCDC80.b 299 to 848 2 to 552   capped   551/551
(100 %)
2 diff
(99.7 %id)
DA033120   CCDC80.b 300 to 838 2 to 540   capped   539/539
(100 %)
1 diff
(99.9 %id)
DA545446   CCDC80.b 300 to 855 2 to 558   capped   557/557
(100 %)
3 diff
(99.5 %id)
DA558059   CCDC80.b 300 to 880 2 to 582   capped   581/581
(100 %)
2 diff
(99.7 %id)
DA558100   CCDC80.b 300 to 881 2 to 583   capped   582/582
(100 %)
2 diff
(99.7 %id)
DA657858   CCDC80.b 300 to 838 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DA658481   CCDC80.b 300 to 766 2 to 471   capped   470/471
(99 %)
4 diff
(99.2 %id)
DA663580   CCDC80.b 300 to 864 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
DB126156 thymus CCDC80.b 300 to 858 2 to 558   capped   557/557
(100 %)
2 diff
(99.7 %id)
DA026517   CCDC80.b 301 to 890 2 to 591   capped   590/590
(100 %)
1 diff
(99.9 %id)
DA033564   CCDC80.b 301 to 876 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA444564 tongue, tumor tissue CCDC80.b 301 to 861 2 to 561   capped   560/560
(100 %)
2 diff
(99.7 %id)
DA446174 tongue, tumor tissue CCDC80.b 301 to 848 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
DA448884 tongue, tumor tissue CCDC80.b 301 to 864 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
DA573459   CCDC80.b 301 to 833 2 to 535   capped   534/534
(100 %)
3 diff
(99.5 %id)
DA577233   CCDC80.b 301 to 847 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
DA577475   CCDC80.b 301 to 847 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DA580277   CCDC80.b 301 to 866 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DA660195   CCDC80.b 301 to 872 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA748456   CCDC80.b 301 to 868 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA763386 tongue CCDC80.b 301 to 862 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
DA847956 placenta CCDC80.b 301 to 874 2 to 574   capped   573/574
(99 %)
2 diff
(99.7 %id)
DA860390 placenta CCDC80.b 301 to 864 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DA924399 small intestine CCDC80.b 301 to 876 2 to 577   capped   576/576
(100 %)
3 diff
(99.5 %id)
DA988611 synovial membrane tissue from rheumatioidarthritis CCDC80.b 301 to 814 2 to 515   capped   514/514
(100 %)
1 diff
(99.9 %id)
DB200250 trachea CCDC80.b 301 to 870 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
AY548106   CCDC80.b 302 to 4270 1 to 3969 exact tiling clone, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 3969/3969
(100 %)
0 diff
(100 %id)
AY548107   CCDC80.b 302 to 4106 1 to 3805 exact AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 3805/3805
(100 %)
0 diff
(100 %id)
CN372970 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells CCDC80.b 303 to 1029 1 to 727       727/727
(100 %)
2 diff
(99.8 %id)
DA553391   CCDC80.b 304 to 883 2 to 581   capped   580/580
(100 %)
2 diff
(99.7 %id)
DA547863   CCDC80.b 306 to 872 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DA559040   CCDC80.b 306 to 868 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
DA559404   CCDC80.b 306 to 867 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA579508   CCDC80.b 306 to 852 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
DA579982   CCDC80.b 306 to 864 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA663326   CCDC80.b 307 to 867 2 to 562   capped   561/561
(100 %)
2 diff
(99.7 %id)
DA550092   CCDC80.b 308 to 895 2 to 589   capped   588/589
(99 %)
2 diff
(99.7 %id)
DA662314   CCDC80.b 308 to 878 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA559089   CCDC80.b 310 to 864 2 to 556   capped   555/555
(100 %)
4 diff
(99.3 %id)
DA575067   CCDC80.b 310 to 888 2 to 581   capped   580/580
(100 %)
2 diff
(99.7 %id)
DA597232   CCDC80.b 310 to 867 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
TI_154101959   CCDC80.b 311 to 1007 788 to 94       695/993
(69 %)
0 diff
(100 %id)
DA050751   CCDC80.b 312 to 885 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
DA555255   CCDC80.b 312 to 874 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DB288617 uterus CCDC80.b 312 to 877 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA678337   CCDC80.b 314 to 1089 2 to 778   capped   777/784
(99 %)
6 diff
(99.3 %id)
CN372974 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells CCDC80.b 317 to 681 1 to 365       365/365
(100 %)
0 diff
(100 %id)
BQ890604 eye, normal pigmented retinal epithelium CCDC80.b 325 to 1207 1 to 888       888/897
(98 %)
28 diff
(96.9 %id)
CN372976 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells CCDC80.b 327 to 977 1 to 651       651/651
(100 %)
3 diff
(99.6 %id)
DA544411   CCDC80.b 333 to 891 2 to 560   capped   559/559
(100 %)
2 diff
(99.7 %id)
DA543431   CCDC80.b 334 to 895 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
DA546850   CCDC80.b 334 to 881 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
DB205935 trachea CCDC80.b 336 to 923 2 to 589   capped   588/588
(100 %)
1 diff
(99.9 %id)
DA573841   CCDC80.b 337 to 900 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
DA163132 amygdala CCDC80.b 339 to 917 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
DA580242   CCDC80.b 339 to 912 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA580631   CCDC80.b 342 to 906 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA544102   CCDC80.b 347 to 908 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
DA029461   CCDC80.b 349 to 927 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA021436   CCDC80.b 350 to 923 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA478659   CCDC80.b 350 to 918 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA577889   CCDC80.b 350 to 916 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DA553059   CCDC80.b 353 to 913 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA451848 tongue, tumor tissue CCDC80.b 361 to 948 2 to 589   capped   588/588
(100 %)
3 diff
(99.5 %id)
DB287533 uterus CCDC80.b 367 to 947 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DA557840   CCDC80.b 372 to 949 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DA966042 stomach CCDC80.b 372 to 939 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA575380   CCDC80.b 373 to 929 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
BC116178 PCR rescued clones CCDC80.b 385 to 4569 1 to 4185 exact     4185/4186
(99 %)
1 diff
(100.0 %id)
BC116179 PCR rescued clones CCDC80.b 385 to 4569 1 to 4186 M554D K555E N556E E557*     4186/4187
(99 %)
2 diff
(100.0 %id)
BX647817 endometrium CCDC80.b 986 to 4808 1 to 3823 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 3823/3823
(100 %)
2 diff
(100.0 %id)
AL833034 stomach CCDC80.b 1004 to 4106 1 to 3103 exact available from DKFZ, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 3103/3103
(100 %)
0 diff
(100 %id)
DB323599   CCDC80.b 2211 to 2746 536 to 1       536/538
(99 %)
0 diff
(100 %id)
AI218267 pooled CCDC80.c 1 to 435 435 to 1   tiling clone,   435/435
(100 %)
1 diff
(99.8 %id)
DA442901 tongue, tumor tissue CCDC80.c 342 to 910 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DA678520   CCDC80.c 343 to 911 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DA023524   CCDC80.c 349 to 912 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
AY333429   CCDC80.c 349 to 4077 1 to 3729 exact tiling clone,   3729/3729
(100 %)
0 diff
(100 %id)
DA024724   CCDC80.c 350 to 911 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA030310   CCDC80.c 350 to 925 2 to 577   capped   576/576
(100 %)
3 diff
(99.5 %id)
DA420236 cervix CCDC80.c 350 to 912 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA473465   CCDC80.c 350 to 917 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DA551732   CCDC80.c 350 to 827 2 to 479   capped   478/478
(100 %)
0 diff
(100 %id)
DA551906   CCDC80.c 350 to 879 2 to 531   capped   530/530
(100 %)
0 diff
(100 %id)
DA573306   CCDC80.c 350 to 1060 2 to 715   capped   714/842
(84 %)
8 diff
(99.1 %id)
DA577454   CCDC80.c 350 to 924 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
DA973605 synovial membrane tissue from rheumatioidarthritis CCDC80.c 350 to 906 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DB252923 uterus CCDC80.c 350 to 918 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DB276327 uterus CCDC80.c 350 to 870 2 to 522   capped   521/521
(100 %)
0 diff
(100 %id)
DA766572 tongue CCDC80.c 354 to 923 2 to 570   capped   569/569
(100 %)
2 diff
(99.7 %id)
DB253634 uterus CCDC80.c 354 to 880 2 to 528   capped   527/527
(100 %)
0 diff
(100 %id)
CN372985 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells CCDC80.c 357 to 1082 1 to 726       726/726
(100 %)
7 diff
(99.1 %id)
CN372988 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells CCDC80.c 359 to 955 1 to 598       598/598
(100 %)
5 diff
(99.2 %id)
DA026396   CCDC80.c 360 to 785 2 to 427   capped   426/426
(100 %)
0 diff
(100 %id)
DA331753 hippocampus CCDC80.c 360 to 950 2 to 592   capped   591/591
(100 %)
1 diff
(99.9 %id)
CN372969 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells CCDC80.c 360 to 1027 1 to 668       668/668
(100 %)
3 diff
(99.6 %id)
DA996209 synovial membrane tissue from rheumatioidarthritis CCDC80.c 360 to 924 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DB292080 uterus CCDC80.c 360 to 955 2 to 597   capped   596/596
(100 %)
0 diff
(100 %id)
DN992470 brain, whole brain CCDC80.c 362 to 1035 33 to 706       674/706
(95 %)
6 diff
(99.2 %id)
DA019748   CCDC80.c 367 to 936 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA021987   CCDC80.c 367 to 870 2 to 505   capped   504/504
(100 %)
0 diff
(100 %id)
DA552596   CCDC80.c 367 to 930 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DB268598 uterus CCDC80.c 368 to 936 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
BX647117 colon endothel, primary cell culture CCDC80.c 372 to 4077 1 to 3706 exact available from DKFZ, AAA   3706/3706
(100 %)
0 diff
(100 %id)
CA406834 adipose CCDC80.c 384 to 1164 1 to 776       776/784
(98 %)
6 diff
(99.3 %id)
CN373003 embryonic stem cells, cell lines H1, H7, andH9 CCDC80.c 384 to 1097 1 to 714       714/714
(100 %)
2 diff
(99.8 %id)
DA549305   CCDC80.c 419 to 998 2 to 582   capped   581/581
(100 %)
1 diff
(99.9 %id)
DA025386   CCDC80.c 421 to 984 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DB084871 testis CCDC80.c 426 to 998 2 to 574   capped   573/573
(100 %)
2 diff
(99.7 %id)
DA576986   CCDC80.c 428 to 1010 2 to 585   capped   584/584
(100 %)
3 diff
(99.5 %id)
DA554970   CCDC80.c 429 to 1006 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DA576001   CCDC80.c 433 to 1001 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
CN373004 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells CCDC80.c 437 to 1161 1 to 725       725/725
(100 %)
0 diff
(100 %id)
BX422215 fetal liver, Liver CCDC80.c 439 to 1558 1 to 1107       1107/1133
(97 %)
24 diff
(97.9 %id)
DA927130 small intestine CCDC80.c 528 to 1102 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA061495 cerebellum CCDC80.c 531 to 1092 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DB283247 uterus CCDC80.c 531 to 1077 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DA031308   CCDC80.c 533 to 1111 2 to 579   capped   578/578
(100 %)
2 diff
(99.7 %id)
DA051701   CCDC80.c 533 to 1138 2 to 608   capped   607/607
(100 %)
1 diff
(99.9 %id)
DA553454   CCDC80.c 557 to 1109 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA706741   CCDC80.c 558 to 1130 2 to 574   capped   573/573
(100 %)
2 diff
(99.7 %id)
AK292881 trachea CCDC80.c 562 to 4077 1 to 3516 K672E     3516/3516
(100 %)
1 diff
(100.0 %id)
DB223377 trachea CCDC80.c 563 to 1138 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA020621   CCDC80.c 574 to 1135 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA025385   CCDC80.c 574 to 1140 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA027890   CCDC80.c 574 to 1140 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA574654   CCDC80.c 574 to 1139 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DB280778 uterus CCDC80.c 574 to 1119 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA543921   CCDC80.c 577 to 951 2 to 376   capped   375/375
(100 %)
0 diff
(100 %id)
DA762659 tongue CCDC80.c 577 to 1155 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA981350 synovial membrane tissue from rheumatioidarthritis CCDC80.c 577 to 1154 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DB120904 thymus CCDC80.c 577 to 1151 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
DB250027 uterus CCDC80.c 577 to 1115 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DB263393 uterus CCDC80.c 590 to 1182 2 to 596   capped   595/595
(100 %)
2 diff
(99.7 %id)
DA147750 amygdala CCDC80.c 591 to 1169 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA930092 small intestine CCDC80.c 591 to 1186 2 to 597   capped   596/596
(100 %)
2 diff
(99.7 %id)
DA981635 synovial membrane tissue from rheumatioidarthritis CCDC80.c 591 to 1169 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA908602   CCDC80.c 592 to 1166 2 to 578   capped   577/577
(100 %)
3 diff
(99.5 %id)
DA028280   CCDC80.c 593 to 1166 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
DA028333   CCDC80.c 594 to 1165 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DA693198   CCDC80.c 594 to 1170 2 to 579   capped   578/579
(99 %)
4 diff
(99.4 %id)
DA987307 synovial membrane tissue from rheumatioidarthritis CCDC80.c 594 to 1172 2 to 581   capped   580/580
(100 %)
1 diff
(99.9 %id)
DA575226   CCDC80.c 595 to 1165 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
DA395792 thalamus CCDC80.c 598 to 1194 2 to 598   capped   597/597
(100 %)
0 diff
(100 %id)
DA910355   CCDC80.c 609 to 1175 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
CN372975 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells CCDC80.c 614 to 1211 1 to 597       597/597
(100 %)
2 diff
(99.7 %id)
BX424930 placenta CCDC80.c 617 to 1711 1 to 1089       1089/1095
(99 %)
18 diff
(98.4 %id)
CN372984 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells CCDC80.c 617 to 1193 1 to 577       577/577
(100 %)
2 diff
(99.7 %id)
TI_57152070   CCDC80.c 618 to 1475 61 to 918       858/922
(93 %)
41 diff
(95.6 %id)
CN372996 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells CCDC80.c 619 to 1295 1 to 676       676/676
(100 %)
4 diff
(99.5 %id)
BI763566 pooled colon, kidney, stomach CCDC80.c 623 to 1475 1 to 853       853/857
(99 %)
36 diff
(95.8 %id)
DN995992 breast cancer, Mammary gland (cancer tissue) CCDC80.c 632 to 1241 9 to 618       610/618
(98 %)
6 diff
(99.1 %id)
CN481466 eye CCDC80.c 643 to 1255 1 to 613       613/613
(100 %)
4 diff
(99.4 %id)
AB052098   CCDC80.c 646 to 4077 18 to 3449 exact AAA   3432/3449
(99 %)
8 diff
(99.8 %id)
AL710791 human skeletal muscle CCDC80.c 655 to 1362 1 to 708       708/708
(100 %)
3 diff
(99.6 %id)
DA042601 bladder CCDC80.c 658 to 1163 2 to 507   capped   506/506
(100 %)
0 diff
(100 %id)
DA580472   CCDC80.c 658 to 1228 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA560647 heart CCDC80.c 673 to 1230 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA834610 placenta CCDC80.c 673 to 1140 2 to 469   capped   468/468
(100 %)
0 diff
(100 %id)
DB244643 uterus, tumor tissue CCDC80.c 675 to 1236 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA577736   CCDC80.c 677 to 1258 2 to 583   capped   582/582
(100 %)
1 diff
(99.9 %id)
BX473349   CCDC80.c 678 to 1378 1 to 700       700/700
(100 %)
2 diff
(99.8 %id)
CK000112 mixed CCDC80.c 681 to 1425 1 to 745       745/745
(100 %)
3 diff
(99.6 %id)
BC086876 Chondrosarcoma, myxoid chondrosarcoma GradeII, mixture of 3 cell lines, enriched for 3-4 Kb mRNA CCDC80.c 688 to 2731 1 to 2045       2045/2045
(100 %)
6 diff
(99.8 %id)
DA556431   CCDC80.c 715 to 1276 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA561887 heart CCDC80.c 731 to 1230 2 to 501   capped   500/500
(100 %)
0 diff
(100 %id)
AY726593   CCDC80.c 792 to 4004 1 to 3212 S837N S838V V839L V840L E841S ...     3213/3212
(100 %)
4 diff
(99.9 %id)
BQ952996 carcinoma, cell line, Prostate CCDC80.c 792 to 1603 1 to 820       820/967
(84 %)
28 diff
(97.2 %id)
CN372982 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells CCDC80.c 804 to 1485 1 to 682       682/682
(100 %)
0 diff
(100 %id)
BG117983 adenocarcinoma, cell line, Liver CCDC80.c 866 to 1583 1 to 709       709/712
(99 %)
12 diff
(98.4 %id)
CN372967 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells CCDC80.c 876 to 1514 1 to 640       640/640
(100 %)
1 diff
(99.9 %id)
CN372971 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells CCDC80.c 878 to 1548 1 to 672       672/672
(100 %)
1 diff
(99.9 %id)
CB265906 adipose CCDC80.c 901 to 1298 1 to 398       398/398
(100 %)
0 diff
(100 %id)
CN372980 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells CCDC80.c 902 to 1589 1 to 689       689/689
(100 %)
1 diff
(99.9 %id)
DA719162   CCDC80.c 929 to 1492 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DB125904 thymus CCDC80.c 932 to 1487 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
CN373005 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells CCDC80.c 956 to 1664 1 to 709       709/709
(100 %)
2 diff
(99.8 %id)
ES307467 beard hair, skin CCDC80.c 956 to 1119 1 to 164       164/164
(100 %)
0 diff
(100 %id)
DA821244 pericardium CCDC80.c 982 to 1548 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA996443   CCDC80.c 982 to 1518 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
DA562525 heart CCDC80.c 1019 to 1590 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
BQ695226 adipose CCDC80.c 1064 to 1647 1 to 584       584/584
(100 %)
1 diff
(99.9 %id)
AL701186 human skeletal muscle CCDC80.c 1069 to 1657 1 to 589       589/589
(100 %)
3 diff
(99.5 %id)
DB260490 uterus CCDC80.c 1070 to 1641 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DB263256 uterus CCDC80.c 1070 to 1658 2 to 590   capped   589/589
(100 %)
0 diff
(100 %id)
DB265078 uterus CCDC80.c 1070 to 1648 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
CN372983 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells CCDC80.c 1072 to 1684 1 to 613       613/613
(100 %)
1 diff
(99.9 %id)
DA595132 lung CCDC80.c 1074 to 1663 2 to 592   capped   591/591
(100 %)
3 diff
(99.5 %id)
DA967659 stomach CCDC80.c 1074 to 1641 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA996971   CCDC80.c 1080 to 1428 2 to 350   capped   349/349
(100 %)
0 diff
(100 %id)
BQ718953 sympathetic trunk CCDC80.c 1088 to 1948 41 to 913       873/920
(94 %)
32 diff
(96.6 %id)
FN053254 breast carcinoma CCDC80.c 1092 to 1199 108 to 1     Submitted on the opposite strand 108/108
(100 %)
0 diff
(100 %id)
BQ890445 dorsal root ganglia CCDC80.c 1097 to 1959 1 to 867       867/939
(92 %)
11 diff
(98.9 %id)
CN373002 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells CCDC80.c 1180 to 1882 1 to 703       703/703
(100 %)
2 diff
(99.8 %id)
BM712679 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid CCDC80.c 1180 to 1788 1 to 609       609/609
(100 %)
0 diff
(100 %id)
BE313814 brain, neuroblastoma CCDC80.c 1222 to 1724 1 to 503       503/503
(100 %)
0 diff
(100 %id)
TI_154196908   CCDC80.c 1243 to 2078 8 to 838       831/1084
(76 %)
6 diff
(99.5 %id)
TI_154197292   CCDC80.c 1251 to 2019 76 to 838       763/971
(78 %)
22 diff
(97.8 %id)
BC042128 Eye, normal, pigmented retinal epithelium CCDC80.c 1315 to 2746 1 to 1429   available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 1429/1446
(98 %)
13 diff
(99.2 %id)
BC023639 Eye, normal, pigmented retinal epithelium CCDC80.c 1315 to 2746 1 to 1429   available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 1429/1449
(98 %)
13 diff
(99.2 %id)
BF915045 uterus_tumor CCDC80.c 1431 to 2041 612 to 1     Submitted on the opposite strand 612/612
(100 %)
2 diff
(99.7 %id)
BF037378 adenocarcinoma, ovary CCDC80.c 1458 to 2088 1 to 632       632/854
(74 %)
3 diff
(99.7 %id)
BF915582 uterus_tumor CCDC80.c 1482 to 2041 559 to 1     Submitted on the opposite strand 559/559
(100 %)
2 diff
(99.7 %id)
CN372968 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells CCDC80.c 1526 to 2223 1 to 698       698/698
(100 %)
5 diff
(99.3 %id)
ES315317 occipital scalp hair, skin CCDC80.c 1552 to 1709 1 to 158       158/158
(100 %)
0 diff
(100 %id)
DA880968   CCDC80.c 1599 to 2155 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA033886   CCDC80.c 1604 to 2178 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
CN372979 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells CCDC80.c 1653 to 2346 1 to 696       696/696
(100 %)
2 diff
(99.8 %id)
W55850 melanocyte CCDC80.c 1665 to 2323 1 to 662   fully sequenced, Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 662/662
(100 %)
38 diff
(94.3 %id)
BM717953 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid CCDC80.c 1759 to 2088 1 to 330   fully sequenced,   330/330
(100 %)
0 diff
(100 %id)
CB158276 Liver CCDC80.c 1779 to 1930 1 to 152       152/152
(100 %)
0 diff
(100 %id)
CB158548 Liver CCDC80.c 1779 to 2274 1 to 496       496/496
(100 %)
0 diff
(100 %id)
TI_149313984   CCDC80.c 1835 to 2716 1005 to 136       870/1066
(81 %)
0 diff
(100 %id)
DA476453   CCDC80.c 1842 to 2414 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
TI_154101388   CCDC80.c 1895 to 2731 886 to 62   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 825/892
(92 %)
0 diff
(100 %id)
TI_154101218   CCDC80.c 1944 to 2731 850 to 68   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 783/896
(87 %)
0 diff
(100 %id)
CO250205 Chondrosarcoma Lung Metastasis cell lines, lung CCDC80.c 1950 to 2671 1 to 719       719/759
(94 %)
6 diff
(99.3 %id)
BQ695130 adipose CCDC80.c 1952 to 2372 1 to 421       421/421
(100 %)
0 diff
(100 %id)
TI_149272358   CCDC80.c 1952 to 2825 933 to 65       869/1102
(78 %)
0 diff
(100 %id)
TI_154101215   CCDC80.c 1969 to 2731 815 to 61   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 755/874
(86 %)
0 diff
(100 %id)
AA036654 heart CCDC80.c 1996 to 2299 1 to 304   fully sequenced,   304/304
(100 %)
0 diff
(100 %id)
CB851484 lung, Primary Lung Cystic Fibrosis EpithelialCells CCDC80.c 2003 to 2731 734 to 6   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 729/734
(99 %)
0 diff
(100 %id)
CD245776 White Matter CCDC80.c 2030 to 2915 19 to 902       884/904
(97 %)
27 diff
(97.1 %id)
BM007681 Spleen CCDC80.c 2045 to 2607 1 to 567       567/567
(100 %)
8 diff
(98.6 %id)
TI_154033048   CCDC80.c 2045 to 2720 250 to 916   AAA Submitted on the opposite strand 667/916
(72 %)
18 diff
(98.1 %id)
CA443162 lung, Metastatic Chondrosarcoma CCDC80.c 2045 to 2523 190 to 666     Submitted on the opposite strand 477/666
(71 %)
6 diff
(99.1 %id)
CA443296 lung, Metastatic Chondrosarcoma CCDC80.c 2045 to 2551 190 to 695     Submitted on the opposite strand 506/695
(72 %)
5 diff
(99.3 %id)
TI_59382914   CCDC80.c 2046 to 2607 63 to 628       566/566
(100 %)
7 diff
(98.8 %id)
BM676028 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid CCDC80.c 2047 to 2729 682 to 1       682/682
(100 %)
5 diff
(99.3 %id)
BQ005724 Chondrosarcoma, Left Pubic Bone CCDC80.c 2048 to 2737 691 to 2   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 690/691
(99 %)
0 diff
(100 %id)
BU742162 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid CCDC80.c 2058 to 2738 679 to 1   fully sequenced,   679/679
(100 %)
5 diff
(99.3 %id)
BU528616 epidermoid carcinoma, cell line, lung CCDC80.c 2077 to 2737 675 to 9   AAA Submitted on the opposite strand 667/841
(79 %)
0 diff
(100 %id)
BQ019818 Chondrosarcoma, Left Pubic Bone CCDC80.c 2096 to 2737 643 to 2   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 642/643
(99 %)
0 diff
(100 %id)
BM997012 Chondrosarcoma, Left Pubic Bone CCDC80.c 2096 to 2737 643 to 2   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 642/643
(99 %)
0 diff
(100 %id)
BE272411 adenocarcinoma cell line, ovary CCDC80.c 2101 to 2580 1 to 478       478/496
(96 %)
19 diff
(96.2 %id)
BQ894770 dorsal root ganglia CCDC80.c 2105 to 2939 1 to 840       840/845
(99 %)
8 diff
(99.1 %id)
TI_154098317   CCDC80.c 2107 to 2731 696 to 75   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 622/779
(79 %)
0 diff
(100 %id)
BQ949043 sciatic nerve CCDC80.c 2108 to 2971 12 to 875       864/876
(98 %)
9 diff
(99.0 %id)
BX415050 thymus CCDC80.c 2115 to 3075 44 to 1000       957/1019
(93 %)
24 diff
(97.7 %id)
BQ017846 Chondrosarcoma, Left Pubic Bone CCDC80.c 2117 to 2729 612 to 1       612/612
(100 %)
5 diff
(99.2 %id)
BQ020085 Chondrosarcoma, Left Pubic Bone CCDC80.c 2127 to 2737 613 to 2   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 612/613
(99 %)
0 diff
(100 %id)
BU623240 cell lines, Chondrosarcoma CCDC80.c 2139 to 2740 603 to 2   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 602/603
(99 %)
0 diff
(100 %id)
CA439919 lung, Lung Focal Fibrosis CCDC80.c 2140 to 2740 602 to 2   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 601/602
(99 %)
0 diff
(100 %id)
CA441860 Chondrosarcoma, Left Pubic Bone CCDC80.c 2140 to 2729 589 to 1       589/589
(100 %)
5 diff
(99.2 %id)
CA441736 Chondrosarcoma, Left Pubic Bone CCDC80.c 2140 to 2729 589 to 1       589/589
(100 %)
5 diff
(99.2 %id)
AA570507 Schwannoma tumor CCDC80.c 2162 to 2723 561 to 1       561/561
(100 %)
3 diff
(99.5 %id)
DA597806   CCDC80.c 2191 to 2751 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
CN372986 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells CCDC80.c 2194 to 2598 1 to 405       405/405
(100 %)
0 diff
(100 %id)
CA422040 Bone, Enchondroma cell line CCDC80.c 2197 to 2792 614 to 19   AAA   596/596
(100 %)
1 diff
(99.9 %id)
BU675018 lung, Primary Lung Epithelial Cells CCDC80.c 2199 to 2824 625 to 1       625/625
(100 %)
8 diff
(98.8 %id)
BU617144 Bone, Subchondral Bone CCDC80.c 2213 to 2731 520 to 5   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 516/520
(99 %)
0 diff
(100 %id)
BU627854 Bone, Enchondroma cell line CCDC80.c 2213 to 2824 609 to 1       609/609
(100 %)
9 diff
(98.6 %id)
AI971415 pooled germ cell tumors CCDC80.c 2245 to 2713 472 to 1       472/472
(100 %)
3 diff
(99.4 %id)
CA312016 Human Lung Epithelial cells, lung CCDC80.c 2248 to 2825 594 to 16   AAA   579/579
(100 %)
1 diff
(99.9 %id)
AA410929 ovarian tumor, ovary CCDC80.c 2256 to 2663 1 to 407       407/409
(99 %)
3 diff
(99.3 %id)
BM990159 lung, Metastatic Chondrosarcoma CCDC80.c 2265 to 2807 544 to 2       543/544
(99 %)
5 diff
(99.1 %id)
AA063585 heart CCDC80.c 2269 to 2714 448 to 1   fully sequenced,   448/448
(100 %)
4 diff
(99.2 %id)
AI371013 brain, glioblastoma (pooled) CCDC80.c 2272 to 2714 443 to 1       443/443
(100 %)
0 diff
(100 %id)
AI147536 Kidney CCDC80.c 2274 to 2714 441 to 1       441/441
(100 %)
0 diff
(100 %id)
ES309257 occipital hair of pubic hypotrichosispatient, skin CCDC80.c 2276 to 2856 31 to 605       575/810
(70 %)
13 diff
(98.4 %id)
N75819.
matches multiple genes
lung CCDC80.c 2290 to 2722 440 to 1     also hits gene C2orf28 440/445
(98 %)
17 diff
(96.2 %id)
AW005418 anaplastic oligodendroglioma, brain CCDC80.c 2292 to 2714 423 to 1       423/426
(99 %)
0 diff
(100 %id)
AA416767   CCDC80.c 2293 to 2711 421 to 3       419/421
(99 %)
0 diff
(100 %id)
N66832 melanocyte CCDC80.c 2302 to 2716 423 to 5   fully sequenced, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 419/423
(99 %)
0 diff
(100 %id)
AI083516 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus CCDC80.c 2302 to 2712 411 to 1       411/411
(100 %)
0 diff
(100 %id)
AI698032 carcinoid, lung CCDC80.c 2305 to 2708 409 to 6       404/409
(98 %)
0 diff
(100 %id)
CD517202 White Matter CCDC80.c 2310 to 3105 1 to 802       802/878
(91 %)
11 diff
(98.8 %id)
BU625901 cell lines, Enchondroma CCDC80.c 2315 to 2731 418 to 2   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 417/419
(99 %)
0 diff
(100 %id)
AI936116 normal prostate, Prostate CCDC80.c 2321 to 2718 398 to 1       398/398
(100 %)
2 diff
(99.5 %id)
CN372998 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 CCDC80.c 2329 to 2822 1 to 494   AAA   494/494
(100 %)
0 diff
(100 %id)
AI079893   CCDC80.c 2331 to 2722 393 to 2       392/393
(99 %)
0 diff
(100 %id)
AA747741 pooled germ cell tumors CCDC80.c 2334 to 2714 381 to 1       381/381
(100 %)
2 diff
(99.5 %id)
AL702159 human skeletal muscle CCDC80.c 2343 to 2909 1 to 567       567/567
(100 %)
1 diff
(99.9 %id)
AL702151 human skeletal muscle CCDC80.c 2343 to 2960 1 to 618       618/618
(100 %)
0 diff
(100 %id)
BF940413 fibrotheoma, ovary CCDC80.c 2349 to 2718 370 to 1       370/370
(100 %)
0 diff
(100 %id)
AA873147 2 pooled tumors (clear cell type), Kidney CCDC80.c 2372 to 2711 343 to 5       339/343
(98 %)
0 diff
(100 %id)
ES308576 beard hair, skin CCDC80.c 2381 to 2608 1 to 226       226/226
(100 %)
4 diff
(98.3 %id)
AW305114 brain, three pooled meningiomas CCDC80.c 2409 to 2822 414 to 1       414/414
(100 %)
0 diff
(100 %id)
FN126759 breast carcinoma CCDC80.c 2422 to 2476 1 to 55       55/56
(98 %)
1 diff
(98.3 %id)
N24008 melanocyte CCDC80.c 2426 to 2710 284 to 1       284/284
(100 %)
4 diff
(98.6 %id)
AW800540 uterus CCDC80.c 2437 to 2810 394 to 23       372/406
(91 %)
7 diff
(98.3 %id)
FN059799 breast carcinoma CCDC80.c 2437 to 2507 1 to 71       71/72
(98 %)
3 diff
(95.9 %id)
CD244831 White Matter CCDC80.c 2499 to 3290 1 to 800       800/979
(81 %)
20 diff
(98.0 %id)
TI_149275864   CCDC80.c 2524 to 3245 125 to 845     Submitted on the opposite strand 721/1081
(66 %)
2 diff
(99.9 %id)
BU676889 lung, Primary Lung Epithelial Cells CCDC80.c 2524 to 3205 50 to 730     Submitted on the opposite strand 681/714
(95 %)
7 diff
(99.1 %id)
CN372987 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells CCDC80.c 2538 to 3216 1 to 678       678/678
(100 %)
5 diff
(99.3 %id)
CB139740 Liver CCDC80.c 2577 to 3082 1 to 506       506/506
(100 %)
0 diff
(100 %id)
AI446798 poorly differentiated adenocarcinoma withsignet ring cell features, stomach CCDC80.c 2579 to 2822 244 to 1       244/244
(100 %)
0 diff
(100 %id)
FN145772 breast carcinoma CCDC80.c 2630 to 2716 85 to 1     Submitted on the opposite strand 85/85
(100 %)
3 diff
(96.5 %id)
BM051031 eye, normal pigmented retinal epithelium CCDC80.c 2689 to 3425 1 to 738       738/738
(100 %)
6 diff
(99.2 %id)
BG253437 adenocarcinoma, cell line, Liver CCDC80.c 2694 to 3396 1 to 702       702/1199
(58 %)
11 diff
(99.1 %id)
AI751036 Bone, Hip CCDC80.c 2751 to 3207 5 to 461       457/461
(99 %)
6 diff
(98.7 %id)
AI751257 Bone, Hip CCDC80.c 2767 to 3227 9 to 469       461/469
(98 %)
0 diff
(100 %id)
BF338364 brain, glioblastoma with EGFR amplification CCDC80.c 2772 to 3496 1 to 729       729/1057
(68 %)
11 diff
(99.0 %id)
CB142444 Liver CCDC80.c 2775 to 3245 1 to 471       471/471
(100 %)
0 diff
(100 %id)
CA405741 adipose CCDC80.c 2839 to 3439 1 to 601       601/601
(100 %)
1 diff
(99.9 %id)
AI752526 Bone, Hip CCDC80.c 2862 to 3270 9 to 417       409/417
(98 %)
0 diff
(100 %id)
BG122685 adenocarcinoma, cell line, Liver CCDC80.c 2882 to 3602 1 to 722       720/723
(99 %)
9 diff
(98.8 %id)
BC073164 Peripheral Nervous System, dorsal rootganglion CCDC80.c 2931 to 4077 1 to 1147   available from MGC, AAA   1147/1147
(100 %)
1 diff
(100.0 %id)
BU151677 dorsal root ganglia CCDC80.c 2932 to 3754 1 to 833   available from MGC,   833/961
(86 %)
15 diff
(98.5 %id)
BQ951817 epidermoid carcinoma, cell line, lung CCDC80.c 3026 to 4003 19 to 1009       991/1010
(98 %)
40 diff
(96.1 %id)
FN154199 breast carcinoma CCDC80.c 3054 to 3139 84 to 1     Submitted on the opposite strand 84/88
(95 %)
2 diff
(97.8 %id)
BM712122 eye, lens CCDC80.c 3055 to 3522 1 to 468   fully sequenced,   468/468
(100 %)
0 diff
(100 %id)
TI_154135149   CCDC80.c 3064 to 4077 1073 to 85   AAA   993/990
(100 %)
33 diff
(96.7 %id)
FN052984 breast carcinoma CCDC80.c 3083 to 3171 1 to 89       89/89
(100 %)
0 diff
(100 %id)
BX415049 thymus CCDC80.c 3107 to 4048 941 to 1       941/941
(100 %)
13 diff
(98.7 %id)
CA406550 adipose CCDC80.c 3120 to 3689 1 to 568       568/568
(100 %)
4 diff
(99.3 %id)
BF037455 adenocarcinoma, ovary CCDC80.c 3140 to 3887 1 to 749       749/749
(100 %)
18 diff
(97.6 %id)
D31528   CCDC80.c 3217 to 3476 1 to 260       260/260
(100 %)
0 diff
(100 %id)
AA319726 adipose tissue, white CCDC80.c 3234 to 3536 1 to 303       303/303
(100 %)
0 diff
(100 %id)
TI_149300713   CCDC80.c 3243 to 4077 890 to 60   AAA   831/970
(85 %)
9 diff
(99.1 %id)
TI_154062027   CCDC80.c 3243 to 4077 924 to 99   AAA   826/973
(84 %)
16 diff
(98.4 %id)
TI_154131898   CCDC80.c 3254 to 4077 921 to 100   AAA   822/977
(84 %)
15 diff
(98.5 %id)
TI_149308329   CCDC80.c 3269 to 4077 909 to 108   AAA   802/956
(83 %)
9 diff
(99.1 %id)
BM694869 eye, RPE and Choroid CCDC80.c 3283 to 3610 1 to 328   fully sequenced,   328/328
(100 %)
0 diff
(100 %id)
BQ182849 Knee, Osteoarthritic Cartilage CCDC80.c 3305 to 4077 791 to 19   AAA   773/773
(100 %)
0 diff
(100 %id)
CN372991 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells CCDC80.c 3319 to 3707 1 to 389       389/389
(100 %)
0 diff
(100 %id)
FN172132 breast carcinoma CCDC80.c 3323 to 3432 109 to 1     Submitted on the opposite strand 109/109
(100 %)
2 diff
(98.2 %id)
TI_149305752   CCDC80.c 3347 to 4077 797 to 77   AAA   721/900
(80 %)
10 diff
(98.9 %id)
CA420877 Bone, Enchondroma cell line CCDC80.c 3350 to 4077 745 to 19   AAA   727/727
(100 %)
1 diff
(99.9 %id)
BU608431 Human Lung Epithelial cells, lung CCDC80.c 3352 to 4077 744 to 19   AAA   726/726
(100 %)
0 diff
(100 %id)
BM926563 pooled lung and spleen CCDC80.c 3366 to 4077 1 to 712   AAA   712/712
(100 %)
0 diff
(100 %id)
BU687094 lung, Primary Lung Epithelial Cells CCDC80.c 3385 to 4077 711 to 19   AAA   693/693
(100 %)
0 diff
(100 %id)
TI_154020146   CCDC80.c 3392 to 4077 774 to 89   AAA   686/686
(100 %)
0 diff
(100 %id)
FN063419 breast carcinoma CCDC80.c 3395 to 3480 86 to 1     Submitted on the opposite strand 86/86
(100 %)
0 diff
(100 %id)
C05155 heart CCDC80.c 3441 to 3847 1 to 407       407/407
(100 %)
0 diff
(100 %id)
FN055730 breast carcinoma CCDC80.c 3441 to 3534 94 to 1     Submitted on the opposite strand 94/94
(100 %)
0 diff
(100 %id)
FN164206 breast carcinoma CCDC80.c 3506 to 3621 119 to 1     Submitted on the opposite strand 119/119
(100 %)
5 diff
(95.8 %id)
BM990446 lung, Metastatic Chondrosarcoma CCDC80.c 3515 to 4077 581 to 19   AAA   563/563
(100 %)
0 diff
(100 %id)
BM670418 eye, lens CCDC80.c 3515 to 4077 581 to 19   fully sequenced, AAA   563/563
(100 %)
0 diff
(100 %id)
BQ446406 Knee, Osteoarthritic Cartilage CCDC80.c 3515 to 4077 581 to 19   AAA   563/563
(100 %)
0 diff
(100 %id)
BU731673 eye, RPE and Choroid CCDC80.c 3549 to 4077 547 to 19   fully sequenced, AAA   529/529
(100 %)
0 diff
(100 %id)
AI751258 Bone, Hip CCDC80.c 3556 to 4047 499 to 8       492/499
(98 %)
0 diff
(100 %id)
AA024968 heart CCDC80.c 3645 to 4086 1 to 442       442/442
(100 %)
0 diff
(100 %id)
EL951059 eyeball CCDC80.c 3862 to 4455 7 to 600   tiling clone,   594/600
(99 %)
0 diff
(100 %id)
AI270416 poorly differentiated adenocarcinoma withsignet ring cell features, stomach CCDC80.c 3869 to 4077 209 to 1       209/209
(100 %)
0 diff
(100 %id)
AW674273 cervix CCDC80.c 3924 to 4238 323 to 9       315/323
(97 %)
0 diff
(100 %id)
AA133431 uterus CCDC80.c 3927 to 3978 1 to 52       52/52
(100 %)
0 diff
(100 %id)
FN143921 breast carcinoma CCDC80.c 3930 to 4023 1 to 92       92/95
(96 %)
4 diff
(95.8 %id)
AA709039 uterus CCDC80.c 3960 to 4077 150 to 33   AAA   118/118
(100 %)
0 diff
(100 %id)
FN117720 breast carcinoma CCDC80.c 3994 to 4074 1 to 81       81/85
(95 %)
1 diff
(98.9 %id)
AA382233 testis CCDC80.c 4061 to 4232 181 to 10       172/181
(95 %)
0 diff
(100 %id)
AA382380 testis CCDC80.c 4066 to 4241 176 to 1       176/176
(100 %)
0 diff
(100 %id)
CN360806 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells CCDC80.c 4226 to 4957 1 to 732   tiling clone,   732/732
(100 %)
0 diff
(100 %id)
BM726482 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid CCDC80.c 4251 to 4779 30 to 557   fully sequenced,   528/557
(94 %)
6 diff
(99.0 %id)
AW024492 Kidney CCDC80.c 4289 to 4781 493 to 1       493/493
(100 %)
2 diff
(99.6 %id)
BU740669 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid CCDC80.c 4291 to 4779 504 to 17   fully sequenced, AAA   488/488
(100 %)
0 diff
(100 %id)
AA024662 heart CCDC80.c 4347 to 4781 437 to 1       437/438
(99 %)
8 diff
(98.2 %id)
CA412444 Chondrosarcoma Grade II, Left Pelvis CCDC80.c 4460 to 5180 743 to 19   tiling clone, AAA   725/725
(100 %)
3 diff
(99.6 %id)
CA411751 Chondrosarcoma Grade II, Left Pelvis CCDC80.c 4461 to 5180 742 to 19   tiling clone, AAA   724/724
(100 %)
5 diff
(99.4 %id)
BF001215 Prostate CCDC80.c 4520 to 4779 260 to 1       260/260
(100 %)
0 diff
(100 %id)
AA775524 heart CCDC80.c 4902 to 5183 284 to 3   tiling clone,   282/284
(99 %)
0 diff
(100 %id)
DB291628 uterus CCDC80.c 5093 to 5672 2 to 581   tiling clone, capped   580/580
(100 %)
0 diff
(100 %id)
DA461882 tongue, tumor tissue CCDC80.c 6048 to 6506 2 to 461   tiling clone, capped   460/460
(100 %)
2 diff
(99.6 %id)
AW753754 colon CCDC80.c 6241 to 6495 1 to 253       253/277
(91 %)
11 diff
(96.1 %id)
CN404947 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells CCDC80.c 6267 to 6832 1 to 566   tiling clone,   566/566
(100 %)
0 diff
(100 %id)
DB353068 uterus CCDC80.c 6382 to 6890 510 to 2       509/510
(99 %)
0 diff
(100 %id)
DB279838 uterus CCDC80.c 6433 to 6971 2 to 541   tiling clone, capped   540/540
(100 %)
2 diff
(99.7 %id)
AK304561 uterus CCDC80.d 1 to 3151 4 to 2038 T89G E90R P91F P92R A93D ... tiling clone, Suspected internal deletion 2038/2038
(100 %)
1 diff
(100.0 %id)
Z39942 brain, total brain CCDC80.e 1 to 197 1 to 197     Submitted on the opposite strand 197/197
(100 %)
2 diff
(99.0 %id)
F09910 brain, total brain CCDC80.e 1 to 315 1 to 315   tiling clone, Submitted on the opposite strand 315/315
(100 %)
1 diff
(99.7 %id)
CN281745 embryonic stem cells, cell lines H1, H7, andH9 CCDC80.e 231 to 704 10 to 483       474/483
(98 %)
6 diff
(98.8 %id)
DC419676 uterus CCDC80.e 311 to 633 1 to 323       323/323
(100 %)
0 diff
(100 %id)
DB270168 uterus CCDC80.e 312 to 861 2 to 551   tiling clone, capped   550/550
(100 %)
0 diff
(100 %id)
AK075210 placenta CCDC80.e 321 to 2135 1 to 1815   tiling clone, available from FLJ,   1815/1815
(100 %)
2 diff
(99.9 %id)
DA832874 placenta CCDC80.e 321 to 916 2 to 603   capped   602/607
(99 %)
11 diff
(98.2 %id)
DA026371   CCDC80.e 322 to 876 2 to 556   capped   555/555
(100 %)
2 diff
(99.7 %id)
DA647177 mammary gland CCDC80.e 326 to 1084 2 to 751   capped   750/827
(90 %)
12 diff
(98.6 %id)
ES311116 scalp interfollicular dermis, skin CCDC80.e 372 to 946 69 to 633       565/708
(79 %)
16 diff
(97.8 %id)
F12285 brain, total brain CCDC80.e 1287 to 1530 244 to 1     Submitted on the opposite strand 244/244
(100 %)
0 diff
(100 %id)
DB362018 mammary gland CCDC80.e 1454 to 2027 568 to 1   tiling clone,   568/568
(100 %)
21 diff
(96.4 %id)
DB379291 placenta CCDC80.e 1563 to 2135 575 to 1       575/599
(95 %)
39 diff
(93.5 %id)
CK001364 brain/CNS, Bulk tissue from Human Spinal cord CCDC80.e 1932 to 2630 1 to 698   tiling clone,   698/699
(99 %)
10 diff
(98.6 %id)
DC299168   CCDC80.f 1 to 583 1 to 583   tiling clone,   583/583
(100 %)
0 diff
(100 %id)
DC347945 tongue, tumor tissue CCDC80.f 47 to 605 1 to 560       560/561
(99 %)
5 diff
(99.2 %id)
DC417351 trachea CCDC80.f 92 to 641 1 to 551       551/551
(100 %)
4 diff
(99.3 %id)
DC357386   CCDC80.f 232 to 574 1 to 344       344/344
(100 %)
1 diff
(99.8 %id)
DA994246 synovial membrane tissue from rheumatioidarthritis CCDC80.f 259 to 797 2 to 541   capped   540/540
(100 %)
2 diff
(99.7 %id)
DA913208   CCDC80.f 262 to 824 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA598595   CCDC80.f 435 to 1010 2 to 577   tiling clone, capped   576/576
(100 %)
1 diff
(99.9 %id)
BU568354 testis CCDC80.g 1 to 646 1 to 653   tiling clone,   653/790
(82 %)
33 diff
(95.9 %id)
ES316004 melanoma cell line CCDC80.g 40 to 429 46 to 433   tiling clone,   388/458
(84 %)
15 diff
(96.8 %id)
CR748104   CCDC80.g 44 to 443 1 to 401   tiling clone,   401/401
(100 %)
1 diff
(99.8 %id)
AA446297   CCDC80.g 84 to 461 1 to 379   tiling clone, fully sequenced,   379/379
(100 %)
2 diff
(99.5 %id)
AA446024   CCDC80.g 453 to 886 436 to 3   tiling clone, fully sequenced,   434/436
(99 %)
0 diff
(100 %id)
DA599222   CCDC80.h 1 to 536 4 to 540   tiling clone, capped   539/539
(100 %)
2 diff
(99.7 %id)
DA423426   CCDC80.h 102 to 623 2 to 523 exact tiling clone, capped   522/522
(100 %)
0 diff
(100 %id)
TI_57170923   CCDC80.i 1 to 587 216 to 803 exact tiling clone, AAA   588/803
(73 %)
7 diff
(99.2 %id)
TI_154122000   CCDC80.i 2 to 748 839 to 93   tiling clone, AAA   747/962
(77 %)
3 diff
(99.7 %id)
W65302 heart CCDC80.j-u 1 to 415 1 to 420   tiling clone,   420/420
(100 %)
5 diff
(98.9 %id)
BF326161 amnion_normal CCDC80.j-u 91 to 325 238 to 4   tiling clone,   235/240
(97 %)
0 diff
(100 %id)
W65400 heart CCDC80.j-u 428 to 782 359 to 1   tiling clone,   359/366
(98 %)
9 diff
(97.6 %id)
BX108152 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus CCDC80.j-u 514 to 1000 1 to 487   tiling clone,   487/487
(100 %)
0 diff
(100 %id)
BF031096 hypernephroma, Kidney CCDC80.j-u 632 to 1363 1 to 715       715/858
(83 %)
50 diff
(94.2 %id)
AI417828 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus CCDC80.j-u 928 to 1401 474 to 1   tiling clone,   474/474
(100 %)
0 diff
(100 %id)
AA229368   CCDC80.j-u 1005 to 1403 399 to 1       399/412
(96 %)
8 diff
(98.1 %id)
AA229313   CCDC80.j-u 1005 to 1377 9 to 381       373/381
(97 %)
6 diff
(98.5 %id)
BU618627 Cell Line, Chondrosarcoma CCDC80.j-u 1109 to 1870 775 to 17   tiling clone, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 759/759
(100 %)
2 diff
(99.8 %id)
BF971327 adrenal cortex carcinoma, cell line, adrenal gland CCDC80.j-u 1559 to 2182 1 to 625   tiling clone,   625/626
(99 %)
10 diff
(98.5 %id)
TI_159718281   CCDC80.k-u 1 to 929 1017 to 108 exact tiling clone,   910/1090
(83 %)
0 diff
(100 %id)
DA025000   CCDC80.l-u 1 to 577 2 to 579   tiling clone, capped   578/578
(100 %)
2 diff
(99.7 %id)
CD695854 normal nasopharynx CCDC80.l-u 259 to 855 12 to 608       597/608
(98 %)
6 diff
(99.1 %id)
DA026462   CCDC80.l-u 460 to 1038 2 to 580   tiling clone, capped   579/579
(100 %)
0 diff
(100 %id)
CN482533 eye CCDC80.l-u 599 to 1163 1 to 565       565/565
(100 %)
0 diff
(100 %id)
BX476119   CCDC80.l-u 619 to 1321 1 to 702       702/702
(100 %)
4 diff
(99.5 %id)
AI754692 bone marrow stroma CCDC80.l-u 854 to 1307 474 to 21   AAA   454/454
(100 %)
0 diff
(100 %id)
BF222128 Prostate CCDC80.l-u 968 to 1308 342 to 2   tiling clone,   341/342
(99 %)
0 diff
(100 %id)
CR744742   CCDC80.l-u 1288 to 1973 1 to 683   tiling clone,   683/683
(100 %)
1 diff
(99.9 %id)
BQ364944 stomach_normal CCDC80.l-u 1352 to 1706 349 to 2   tiling clone,   348/349
(99 %)
0 diff
(100 %id)
BM990839 lung, Lung Focal Fibrosis CCDC80.l-u 1594 to 2215 18 to 639     Submitted on the opposite strand 622/639
(97 %)
6 diff
(99.1 %id)
AI023995 liver and spleen CCDC80.l-u 1631 to 2050 420 to 1       420/420
(100 %)
0 diff
(100 %id)
DB295659   CCDC80.l-u 1927 to 2378 452 to 1   tiling clone,   452/453
(99 %)
0 diff
(100 %id)
DA554152   CCDC80.l-u 2322 to 2884 2 to 564 V51A tiling clone, capped   563/563
(100 %)
6 diff
(99.0 %id)
DB282602 uterus CCDC80.l-u 2409 to 2963 2 to 556 exact tiling clone, capped   555/555
(100 %)
0 diff
(100 %id)
AL598476   CCDC80.l-u 2526 to 3244 1 to 719 K12R I13V I16V R20G E31G     719/719
(100 %)
10 diff
(98.7 %id)
DB285720 uterus CCDC80.l-u 2796 to 3345 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DB218512 trachea CCDC80.l-u 2846 to 3379 2 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
DA018242   CCDC80.l-u 2866 to 3413 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
AK126393 uterus CCDC80.l-u 2882 to 5153 1 to 2272   tiling clone, available from FLJ,   2272/2855
(79 %)
5 diff
(99.9 %id)
DB258914 uterus CCDC80.l-u 2883 to 3431 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DB213903 trachea CCDC80.l-u 2985 to 3528 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
DA726264   CCDC80.l-u 3005 to 3581 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
FN109993 breast carcinoma CCDC80.l-u 3101 to 3201 101 to 3     Submitted on the opposite strand 99/101
(98 %)
0 diff
(100 %id)
AA346581 heart CCDC80.l-u 3126 to 3418 1 to 293       293/293
(100 %)
0 diff
(100 %id)
DA764907 tongue CCDC80.l-u 3178 to 3749 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DB295695   CCDC80.l-u 3484 to 4030 547 to 1   tiling clone,   547/547
(100 %)
1 diff
(99.9 %id)
ES313939 beard hair, skin CCDC80.l-u 3587 to 4126 1 to 541       541/541
(100 %)
9 diff
(98.4 %id)
DA987828 synovial membrane tissue from rheumatioidarthritis CCDC80.l-u 3664 to 4226 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
AI268045 carcinoid, lung CCDC80.l-u 3764 to 4181 1 to 417     Submitted on the opposite strand 417/417
(100 %)
3 diff
(99.3 %id)
AI912592 carcinoid, lung CCDC80.l-u 3764 to 4304 1 to 541     Submitted on the opposite strand 541/541
(100 %)
2 diff
(99.7 %id)
BE551249 carcinoid, lung CCDC80.l-u 3764 to 4313 1 to 550     Submitted on the opposite strand 550/550
(100 %)
1 diff
(99.9 %id)
ES307945 beard hair, skin CCDC80.l-u 3808 to 3978 1 to 171       171/171
(100 %)
1 diff
(99.5 %id)
DA538614 Kidney CCDC80.l-u 3853 to 4431 2 to 580   capped   579/579
(100 %)
2 diff
(99.7 %id)
CR737083 carcinoid, lung CCDC80.l-u 3926 to 4401 476 to 1     Submitted on the opposite strand 476/476
(100 %)
1 diff
(99.8 %id)
BE768401 prostate_tumor CCDC80.l-u 4015 to 4355 342 to 3       340/342
(99 %)
0 diff
(100 %id)
AA195773 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus CCDC80.l-u 4028 to 4369 1 to 348       348/348
(100 %)
6 diff
(98.3 %id)
DB264580 uterus CCDC80.l-u 4085 to 4623 2 to 542   capped   541/541
(100 %)
3 diff
(99.5 %id)
CB270562 adipose CCDC80.l-u 4134 to 4614 5 to 478       474/478
(99 %)
6 diff
(98.8 %id)
DB318438   CCDC80.l-u 4141 to 4646 509 to 1       509/511
(99 %)
7 diff
(98.7 %id)
DA602025   CCDC80.l-u 4147 to 4708 2 to 560   capped   559/559
(100 %)
2 diff
(99.7 %id)
DB250752 uterus CCDC80.l-u 4229 to 4795 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DA020263   CCDC80.l-u 4250 to 4817 2 to 569   capped   568/568
(100 %)
3 diff
(99.5 %id)
AA346434 heart CCDC80.l-u 4251 to 4582 1 to 332       332/336
(98 %)
2 diff
(99.5 %id)
AW953045   CCDC80.l-u 4252 to 4880 1 to 629       629/629
(100 %)
1 diff
(99.9 %id)
DB269962 uterus CCDC80.l-u 4302 to 4865 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
DA381541 thalamus CCDC80.l-u 4307 to 4939 2 to 634   capped   633/633
(100 %)
3 diff
(99.6 %id)
DA472447   CCDC80.l-u 4307 to 4874 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
CB270435 adipose CCDC80.l-u 4310 to 4798 1 to 489       489/489
(100 %)
1 diff
(99.8 %id)
AL045000 testis CCDC80.l-u 4350 to 5000 1 to 651       651/651
(100 %)
1 diff
(99.9 %id)
AW750744 colon_normal CCDC80.l-u 4363 to 4587 1 to 225       225/225
(100 %)
11 diff
(95.2 %id)
H59293 liver and spleen CCDC80.l-u 4451 to 4875 1 to 435       435/517
(84 %)
18 diff
(96.6 %id)
AL598887   CCDC80.l-u 4488 to 5063 1 to 576       576/576
(100 %)
1 diff
(99.9 %id)
BG571844 placenta CCDC80.l-u 4529 to 5153 1 to 632       632/896
(70 %)
8 diff
(99.2 %id)
FN140612 breast carcinoma CCDC80.l-u 4577 to 4655 1 to 80       80/81
(98 %)
2 diff
(97.6 %id)
BQ716410 sympathetic trunk CCDC80.l-u 4714 to 5153 1 to 440   tiling clone,   440/871
(50 %)
2 diff
(99.8 %id)
CD702924 normal nasopharynx CCDC80.l-u 4720 to 4869 12 to 163       152/163
(93 %)
6 diff
(96.4 %id)
DA423977   CCDC80.l-u 4729 to 5153 2 to 427   capped   426/568
(75 %)
3 diff
(99.5 %id)
BI870463 adenocarcinoma, cell line, Liver CCDC80.l-u 4884 to 5153 1 to 270       270/857
(31 %)
1 diff
(99.9 %id)
BQ720022 sympathetic trunk CCDC80.l-u 4903 to 5153 1 to 251       251/856
(29 %)
1 diff
(99.9 %id)
AJ318805 adipose tissue CCDC80.m-u 1 to 5102 5218 to 116 F13S K14R A15Q K16R V17L ... tiling clone,   5103/5223
(97 %)
0 diff
(100 %id)
BQ007591 Chondrosarcoma, Left Pubic Bone CCDC80.m-u 239 to 1022 797 to 16   tiling clone,   782/797
(98 %)
0 diff
(100 %id)
TI_57229737   CCDC80.m-u 3525 to 4320 88 to 894   tiling clone,   807/857
(94 %)
28 diff
(96.8 %id)
BG545874 lung CCDC80.m-u 3800 to 4582 1 to 785       785/787
(99 %)
32 diff
(96.0 %id)
FN146240 breast carcinoma CCDC80.m-u 3822 to 3938 117 to 1     Submitted on the opposite strand 117/117
(100 %)
0 diff
(100 %id)
FE192600   CCDC80.m-u 3847 to 4316 117 to 586       470/586
(80 %)
0 diff
(100 %id)
DB351537 uterus CCDC80.m-u 3849 to 4377 531 to 1       531/531
(100 %)
2 diff
(99.7 %id)
AI734951 aorta CCDC80.m-u 3852 to 4372 521 to 1       521/521
(100 %)
0 diff
(100 %id)
AI801249 poorly differentiated adenocarcinoma withsignet ring cell features, stomach CCDC80.m-u 3909 to 4358 1 to 450     Submitted on the opposite strand 450/450
(100 %)
1 diff
(99.8 %id)
AA293777   CCDC80.m-u 3976 to 4410 1 to 435       435/435
(100 %)
0 diff
(100 %id)
AA478747 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus CCDC80.m-u 3986 to 4417 1 to 432       432/432
(100 %)
0 diff
(100 %id)
CN404946 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells CCDC80.m-u 3988 to 4711 1 to 724       724/724
(100 %)
0 diff
(100 %id)
AA121833   CCDC80.m-u 4012 to 4418 1 to 408       408/408
(100 %)
1 diff
(99.8 %id)
BQ883834 dorsal root ganglia CCDC80.m-u 4035 to 4851 1 to 830       830/921
(90 %)
27 diff
(97.1 %id)
CB958107 Pooled-Glandular CCDC80.m-u 4066 to 4721 1 to 664       664/719
(92 %)
12 diff
(98.4 %id)
BF681074 Prostate CCDC80.m-u 4111 to 4814 1 to 716       716/773
(92 %)
56 diff
(92.8 %id)
TI_154109768   CCDC80.m-u 4112 to 5103 1064 to 80   AAA   985/988
(99 %)
16 diff
(98.4 %id)
H30496 breast CCDC80.m-u 4148 to 4591 1 to 450       450/455
(98 %)
11 diff
(97.6 %id)
H27573 breast CCDC80.m-u 4162 to 4507 6 to 355       350/356
(98 %)
6 diff
(98.4 %id)
TI_154106138   CCDC80.m-u 4204 to 5102 977 to 88   AAA   890/1000
(89 %)
15 diff
(98.5 %id)
BF679687 Prostate CCDC80.m-u 4219 to 4894 1 to 667       667/922
(72 %)
15 diff
(98.4 %id)
AW603849 colon_normal CCDC80.m-u 4261 to 4603 344 to 5       340/344
(98 %)
0 diff
(100 %id)
CR735748 heart CCDC80.m-u 4262 to 4543 1 to 283       283/284
(99 %)
3 diff
(99.0 %id)
FN163297 breast carcinoma CCDC80.m-u 4273 to 4393 1 to 122       122/122
(100 %)
1 diff
(99.2 %id)
AA055159 heart CCDC80.m-u 4276 to 4634 1 to 372       372/379
(98 %)
15 diff
(96.1 %id)
TI_154107777   CCDC80.m-u 4302 to 5103 880 to 87   AAA   794/973
(81 %)
8 diff
(99.2 %id)
BE674331 carcinoid, lung CCDC80.m-u 4307 to 4656 350 to 1       350/350
(100 %)
1 diff
(99.8 %id)
CB240675 Human Lung Epithelial cells, lung CCDC80.m-u 4308 to 5100 808 to 19   AAA   790/790
(100 %)
3 diff
(99.7 %id)
BE833430 ovary CCDC80.m-u 4313 to 4599 288 to 3       286/293
(97 %)
0 diff
(100 %id)
BE218136 carcinoid, lung CCDC80.m-u 4340 to 4652 313 to 1       313/313
(100 %)
0 diff
(100 %id)
BQ014489 Chondrosarcoma, Left Pubic Bone CCDC80.m-u 4363 to 5100 756 to 19   AAA   738/738
(100 %)
0 diff
(100 %id)
BM997149 Chondrosarcoma, Left Pubic Bone CCDC80.m-u 4368 to 5100 751 to 19   AAA   733/733
(100 %)
0 diff
(100 %id)
FN172252 breast carcinoma CCDC80.m-u 4394 to 4475 1 to 82       82/82
(100 %)
3 diff
(96.4 %id)
TI_154105358   CCDC80.m-u 4406 to 5102 793 to 96   AAA   698/698
(100 %)
1 diff
(99.9 %id)
BQ008120 Chondrosarcoma, Left Pelvis CCDC80.m-u 4420 to 5103 702 to 19   AAA   684/684
(100 %)
0 diff
(100 %id)
CA448006 Chondrosarcoma, Left Pelvis CCDC80.m-u 4420 to 5103 702 to 19   AAA   684/684
(100 %)
0 diff
(100 %id)
BM996992 Chondrosarcoma, Left Pubic Bone CCDC80.m-u 4422 to 5100 697 to 19   AAA   679/679
(100 %)
0 diff
(100 %id)
CA446628 Chondrosarcoma, Left Pubic Bone CCDC80.m-u 4426 to 5102 693 to 17   AAA   677/677
(100 %)
0 diff
(100 %id)
CA447212 Chondrosarcoma, Left Pelvis CCDC80.m-u 4428 to 5103 694 to 19   AAA   676/676
(100 %)
0 diff
(100 %id)
BQ017199 lung, Metastatic Chondrosarcoma CCDC80.m-u 4457 to 5100 662 to 19   AAA   644/644
(100 %)
5 diff
(99.3 %id)
BQ002955 Chondrosarcoma, Left Pelvis CCDC80.m-u 4483 to 5100 636 to 19   AAA   618/618
(100 %)
0 diff
(100 %id)
BQ017416 lung, Metastatic Chondrosarcoma CCDC80.m-u 4485 to 5100 634 to 19   AAA   616/616
(100 %)
1 diff
(99.9 %id)
BP394560 pancreatic islet CCDC80.m-u 4509 to 5003 496 to 1       496/497
(99 %)
3 diff
(99.4 %id)
BF476341 Prostate CCDC80.m-u 4520 to 5071 552 to 1       552/552
(100 %)
1 diff
(99.9 %id)
BX503487 human spinal cord CCDC80.m-u 4522 to 5099 581 to 4     Submitted on the opposite strand 578/581
(99 %)
0 diff
(100 %id)
AA193340 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus CCDC80.m-u 4523 to 5079 1 to 561   fully sequenced,   561/561
(100 %)
28 diff
(95.1 %id)
FN052079 breast carcinoma CCDC80.m-u 4526 to 4606 1 to 80       80/97
(82 %)
2 diff
(98.0 %id)
DB314582 tongue, tumor tissue CCDC80.m-u 4540 to 5100 561 to 1       561/561
(100 %)
1 diff
(99.9 %id)
BP396708 pancreatic islet CCDC80.m-u 4585 to 5042 1 to 458     Submitted on the opposite strand 458/458
(100 %)
2 diff
(99.6 %id)
AI088063 parathyroid gland, parathyroid tumor CCDC80.m-u 4591 to 5101 517 to 7       511/517
(98 %)
0 diff
(100 %id)
TI_151808946   CCDC80.m-u 4599 to 5100 111 to 612   AAA   502/534
(94 %)
0 diff
(100 %id)
FN114349 breast carcinoma CCDC80.m-u 4601 to 4719 1 to 120       120/120
(100 %)
7 diff
(94.2 %id)
AI755226 bone marrow stroma CCDC80.m-u 4605 to 5100 515 to 20   AAA   496/496
(100 %)
0 diff
(100 %id)
BP395355 pancreatic islet CCDC80.m-u 4606 to 5101 1 to 496     Submitted on the opposite strand 496/500
(99 %)
1 diff
(99.8 %id)
H26818 breast CCDC80.m-u 4606 to 4908 1 to 314       314/355
(88 %)
18 diff
(95.0 %id)
AW337222 adenocarcinoma, Pancreas CCDC80.m-u 4614 to 5101 489 to 2       488/489
(99 %)
0 diff
(100 %id)
BQ185085 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid CCDC80.m-u 4616 to 5100 503 to 19   AAA   485/485
(100 %)
0 diff
(100 %id)
AI379562 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus CCDC80.m-u 4618 to 5102 487 to 3       485/487
(99 %)
0 diff
(100 %id)
AI004295 pooled CCDC80.m-u 4621 to 5101 484 to 4       481/484
(99 %)
0 diff
(100 %id)
TI_154114196   CCDC80.m-u 4625 to 5103 562 to 84   AAA   479/480
(99 %)
0 diff
(100 %id)
AA193440 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus CCDC80.m-u 4640 to 5038 401 to 1   fully sequenced,   401/401
(100 %)
1 diff
(99.8 %id)
AI367162 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus CCDC80.m-u 4643 to 5102 469 to 10       460/469
(98 %)
0 diff
(100 %id)
AI088393 uterus CCDC80.m-u 4650 to 5101 454 to 3       452/454
(99 %)
0 diff
(100 %id)
AI754777 bone marrow stroma CCDC80.m-u 4651 to 5103 476 to 24   AAA   453/453
(100 %)
1 diff
(99.8 %id)
AI754918 bone marrow stroma CCDC80.m-u 4655 to 5100 464 to 19   AAA   446/446
(100 %)
0 diff
(100 %id)
AI288636 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus CCDC80.m-u 4662 to 5102 443 to 3       441/443
(99 %)
0 diff
(100 %id)
AI873529 pooled CCDC80.m-u 4681 to 5099 439 to 21   AAA   419/419
(100 %)
5 diff
(98.9 %id)
AA121834   CCDC80.m-u 4683 to 5100 429 to 12   AAA   418/424
(98 %)
1 diff
(99.8 %id)
AA398351   CCDC80.m-u 4683 to 5101 422 to 4       419/422
(99 %)
0 diff
(100 %id)
BX102889 poorly differentiated adenocarcinoma withsignet ring cell features, stomach CCDC80.m-u 4684 to 5100 431 to 15   AAA   417/417
(100 %)
0 diff
(100 %id)
AI377515 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus CCDC80.m-u 4708 to 5102 395 to 2       394/395
(99 %)
0 diff
(100 %id)
H59249 liver and spleen CCDC80.m-u 4709 to 5102 404 to 3       402/438
(91 %)
0 diff
(100 %id)
BF222165 Prostate CCDC80.m-u 4709 to 5101 400 to 8       393/400
(98 %)
0 diff
(100 %id)
AA195660 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus CCDC80.m-u 4711 to 5102 393 to 2       392/393
(99 %)
0 diff
(100 %id)
AI933630 poorly differentiated adenocarcinoma withsignet ring cell features, stomach CCDC80.m-u 4741 to 5101 363 to 1       363/363
(100 %)
6 diff
(98.4 %id)
H27501 breast CCDC80.m-u 4742 to 5101 377 to 5       373/382
(97 %)
0 diff
(100 %id)
AI933639 poorly differentiated adenocarcinoma withsignet ring cell features, stomach CCDC80.m-u 4744 to 5101 358 to 1       358/358
(100 %)
2 diff
(99.5 %id)
AI338187 lung CCDC80.m-u 4747 to 5100 373 to 20   AAA   354/354
(100 %)
12 diff
(96.7 %id)
FN054216 breast carcinoma CCDC80.m-u 4748 to 4822 75 to 1     Submitted on the opposite strand 75/75
(100 %)
0 diff
(100 %id)
T32653 heart CCDC80.m-u 4760 to 5103 344 to 1       344/344
(100 %)
0 diff
(100 %id)
T32670 heart CCDC80.m-u 4774 to 5103 335 to 1       335/335
(100 %)
6 diff
(98.3 %id)
BE826333 lung_normal CCDC80.m-u 4790 to 5050 25 to 288       264/297
(88 %)
12 diff
(96.0 %id)
C01886   CCDC80.m-u 4800 to 4941 1 to 142       142/146
(97 %)
2 diff
(98.7 %id)
AA055043 heart CCDC80.m-u 4850 to 5100 251 to 1       251/251
(100 %)
0 diff
(100 %id)
DV459351 cochlea, ear CCDC80.m-u 4851 to 5040 3 to 195       193/218
(88 %)
16 diff
(92.7 %id)
BF941165 dorsal root ganglia CCDC80.m-u 4853 to 5101 249 to 1       249/249
(100 %)
0 diff
(100 %id)
AI610241 poorly differentiated adenocarcinoma withsignet ring cell features, stomach CCDC80.m-u 4860 to 5100 241 to 1       241/241
(100 %)
0 diff
(100 %id)
AA479967 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus CCDC80.m-u 4864 to 5102 240 to 2       239/240
(99 %)
0 diff
(100 %id)
FN061103 breast carcinoma CCDC80.m-u 4891 to 4985 1 to 95       95/95
(100 %)
2 diff
(97.9 %id)
Z36962   CCDC80.m-u 4893 to 5104 1 to 212   tiling clone,   212/212
(100 %)
0 diff
(100 %id)
FN113965 breast carcinoma CCDC80.m-u 4941 to 5010 70 to 1     Submitted on the opposite strand 70/71
(98 %)
0 diff
(100 %id)
TI_154044428   CCDC80.n-u 1 to 824 903 to 76 exact tiling clone,   828/1040
(79 %)
0 diff
(100 %id)
CA412444 Chondrosarcoma Grade II, Left Pelvis CCDC80.n-u 101 to 821 743 to 19 exact tiling clone, AAA   725/725
(100 %)
3 diff
(99.6 %id)
CA411751 Chondrosarcoma Grade II, Left Pelvis CCDC80.n-u 102 to 821 742 to 19 exact tiling clone, AAA   724/724
(100 %)
5 diff
(99.4 %id)
DA558726   CCDC80.o 1 to 564 2 to 565 E15G tiling clone, capped   564/564
(100 %)
2 diff
(99.7 %id)
BG216743   CCDC80.p-u 1 to 220 7 to 227 W2S F3G L4F L5I F6V ... tiling clone,   221/227
(97 %)
8 diff
(96.5 %id)
142 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j-u, .k-u, .l-u, .m-u, .n-u, .o, .p-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C